HomeCompareNEV vs KMB

NEV vs KMB: Dividend Comparison 2026

NEV yields 15.99% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NEV wins by $82.1K in total portfolio value
10 years
NEV
NEV
● Live price
15.99%
Share price
$12.51
Annual div
$2.00
5Y div CAGR
11.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$127.9K
Annual income
$25,603.26
Full NEV calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.47
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,211.33
Full KMB calculator →

Portfolio growth — NEV vs KMB

📍 NEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNEVKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NEV + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NEV pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NEV
Annual income on $10K today (after 15% tax)
$1,358.91/yr
After 10yr DRIP, annual income (after tax)
$21,762.77/yr
KMB
Annual income on $10K today (after 15% tax)
$445.84/yr
After 10yr DRIP, annual income (after tax)
$4,429.63/yr
At 15% tax rate, NEV beats the other by $17,333.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NEV + KMB for your $10,000?

NEV: 50%KMB: 50%
100% KMB50/50100% NEV
Portfolio after 10yr
$86.9K
Annual income
$15,407.29/yr
Blended yield
17.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

NEV
No analyst data
Altman Z
1.7
Piotroski
5/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.5% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NEV buys
0
KMB buys
0
No recent congressional trades found for NEV or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNEVKMB
Forward yield15.99%5.25%
Annual dividend / share$2.00$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR11.9%17%
Portfolio after 10y$127.9K$45.9K
Annual income after 10y$25,603.26$5,211.33
Total dividends collected$91.3K$21.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NEV vs KMB ($10,000, DRIP)

YearNEV PortfolioNEV Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$12,489$1,788.97$11,314$613.68+$1.2KNEV
2$15,700$2,336.55$12,865$759.19+$2.8KNEV
3$19,870$3,071.77$14,709$943.96+$5.2KNEV
4$25,327$4,065.84$16,919$1,180.17+$8.4KNEV
5$32,520$5,419.72$19,588$1,484.33+$12.9KNEV
6$42,074$7,277.52$22,838$1,879.06+$19.2KNEV
7$54,866$9,846.74$26,832$2,395.60+$28.0KNEV
8$72,135$13,428.52$31,788$3,077.63+$40.3KNEV
9$95,648$18,463.68$38,000$3,986.82+$57.6KNEV
10$127,947$25,603.26$45,872$5,211.33+$82.1KNEV

NEV vs KMB: Complete Analysis 2026

NEVStock

Nuveen Enhanced Municipal Value Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund invests in undervalued municipal securities and other related investments the income from which is exempt from regular federal income taxes. It seeks to invest in investment grade securities with an average maturity of around 23.00 years. The fund employs fundamental analysis with a focus on bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Dividend Advantage Municipal Fund 3 was formed on July 27, 2009 and is domiciled in the United States.

Full NEV Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this NEV vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NEV vs SCHDNEV vs JEPINEV vs ONEV vs KONEV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.